Daniel K Spiegelman insider trades: Myriad Genetics (MYGN) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Daniel reports to the SEC
and 9 more companies
Open-market buys and sales
44 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 4, 2024 | MYGN | ↓ Sell | 7,576 | $22.04 | $167K | Direct | Jun 4, 2024 (0d) |
| Jun 2, 2023 | MYGN | ↓ Sell | 8,638 | $23.01 | $199K | Direct | Jun 2, 2023 (0d) |
| Jun 6, 2022 | MYGN | ↓ Sell | 6,424 | $19.25 | $124K | Direct | Jun 6, 2022 (0d) |
| Jun 17, 2021 | MYGN | ↓ Sell | 3,139 | $30.52 | $96K | Direct | Jun 17, 2021 (0d) |
| May 28, 2021 | MYGN | ↓ Sell | 7,142 | $28.99 | $207K | Direct | Jun 1, 2021 (4d) |
| Apr 1, 2019 | BMRN | ↓ Sell | 13,473 | $89.00 | $1.2M | Direct | Apr 3, 2019 (2d) |
| Mar 27, 2019 | BMRN | ↓ Sell | 100 | $90.00 | $9K | Direct | Mar 29, 2019 (2d) |
| Jun 22, 2018 | BMRN | ↓ Sell | 10,000 | $99.00 | $990K | Direct | Jun 26, 2018 (4d) |
| Apr 23, 2018 | BMRN | ↓ Sell | 11,059 | $82.15 | $908K | Direct | Apr 25, 2018 (2d) |
| Mar 16, 2017 | BMRN | ↓ Sell | 1,989 | $91.96 | $183K | Direct | Mar 17, 2017 (1d) |
| Mar 6, 2017 | BMRN | ↓ Sell | 2,303 | $93.32 | $215K | Direct | Mar 8, 2017 (2d) |
| Mar 1, 2017 | BMRN | ↓ Sell | 35,000 | $94.07 | $3.3M | Direct | Mar 2, 2017 (1d) |
| Jan 9, 2017 | BMRN | ↓ Sell | 5,000 | $90.00 | $450K | Direct | Jan 10, 2017 (1d) |
| Nov 9, 2016 | BMRN | ↓ Sell | 20,000 | $90.61 | $1.8M | Direct | Nov 14, 2016 (5d) |
| Aug 1, 2016 | BMRN | ↓ Sell | 4,000 | $99.33 | $397K | Direct | Aug 3, 2016 (2d) |
| Jun 7, 2016 | RLYP | ↓ Sell | 1,013 | $19.31 | $20K | Direct | Jun 8, 2016 (1d) |
| Jun 6, 2016 | BMRN | ↓ Sell | 1,649 | $89.14 | $147K | Direct | Jun 8, 2016 (2d) |
| May 31, 2016 | BMRN | ↓ Sell | 20,841 | $89.88 | $1.9M | Direct | Jun 2, 2016 (2d) |
| May 23, 2016 | BMRN | ↓ Sell | 3,769 | $87.07 | $328K | Direct | May 25, 2016 (2d) |
| Mar 2, 2016 | BMRN | ↓ Sell | 4,623 | $86.12 | $398K | Direct | Mar 2, 2016 (0d) |
| Nov 16, 2015 | BMRN | ↓ Sell | 20,000 | $104.30 | $2.1M | Direct | Nov 18, 2015 (2d) |
| Jun 5, 2015 | BMRN | ↓ Sell | 1,649 | $122.30 | $202K | Direct | Jun 8, 2015 (3d) |
| Jun 1, 2015 | BMRN | ↓ Sell | 5,523 | $124.73 | $689K | Direct | Jun 3, 2015 (2d) |
| May 18, 2015 | BMRN | ↓ Sell | 34,078 | $130.00 | $4.4M | Direct | May 28, 2015 (10d) |
| May 18, 2015 | BMRN | ↓ Sell | 2,059 | $124.77 | $257K | Direct | May 19, 2015 (1d) |
| Mar 26, 2015 | ONTY | ↑ Buy | 20,000 | $1.61 | $32K | Direct | Apr 1, 2015 (6d) |
| Mar 2, 2015 | BMRN | ↓ Sell | 15,500 | $107.00 | $1.7M | Direct | Mar 4, 2015 (2d) |
| Sep 3, 2014 | BMRN | ↓ Sell | 41 | $70.61 | $3K | Direct | Feb 10, 2015 (160d) |
| Sep 2, 2014 | BMRN | ↓ Sell | 16,000 | $69.83 | $1.1M | Direct | Sep 3, 2014 (1d) |
| Aug 1, 2014 | BMRN | ↓ Sell | 2,229 | $61.76 | $138K | Direct | Aug 4, 2014 (3d) |
| Jul 2, 2014 | BMRN | ↓ Sell | 2,229 | $64.00 | $143K | Direct | Jul 3, 2014 (1d) |
| Mar 3, 2014 | BMRN | ↓ Sell | 8,000 | $80.32 | $643K | Direct | Mar 5, 2014 (2d) |
| Dec 2, 2013 | BMRN | ↓ Sell | 9,000 | $70.14 | $631K | Direct | Dec 4, 2013 (2d) |
| Sep 4, 2013 | BMRN | ↓ Sell | 9,000 | $69.00 | $621K | Direct | Sep 5, 2013 (1d) |
| Jul 10, 2013 | ONTY | ↓ Sell | 16,183 | $1.91 | $31K | Direct | Oct 8, 2014 (455d) |
| Jul 1, 2013 | BMRN | ↓ Sell | 4,066 | $59.78 | $243K | Direct | Jul 2, 2013 (1d) |
| May 1, 2013 | BMRN | ↓ Sell | 28,000 | $64.42 | $1.8M | Direct | May 3, 2013 (2d) |
| Apr 2, 2009 | CVTX | ↓ Sell | 141,029 | $19.91 | $2.8M | Direct | Apr 3, 2009 (1d) |
| Dec 21, 2007 | CVTX | ↓ Sell | 6,000 | $10.00 | $60K | Direct | Dec 21, 2007 (0d) |
| Dec 10, 2007 | CVTX | ↓ Sell | 8,000 | $10.03 | $80K | Direct | Dec 11, 2007 (1d) |
| Jan 17, 2007 | CVTX | ↓ Sell | 7,000 | $13.93 | $98K | Direct | Jan 18, 2007 (1d) |
| Dec 12, 2006 | CVTX | ↓ Sell | 3,000 | $12.92 | $39K | Direct | Dec 13, 2006 (1d) |
| Nov 3, 2005 | CVTX | ↓ Sell | 26,500 | $25.21 | $668K | Direct | Nov 4, 2005 (1d) |
| Aug 26, 2005 | CVTX | ↓ Sell | 21,506 | $26.24 | $564K | Direct | Aug 30, 2005 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MYGN insiders
Open-market trades in the last 12 months
About Daniel K Spiegelman's insider trades
Daniel K Spiegelman is a director at Myriad Genetics (MYGN). Since Aug 26, 2005, Daniel has reported 1 open-market purchase worth $32K and 43 sales worth $32.0M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (85 filings), shares withheld for taxes (42 filings), option exercises (25 filings), shares returned to the company (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MYGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.